
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5348776
[patent_doc_number] => 20090004137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv'
[patent_app_type] => utility
[patent_app_number] => 11/794032
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17775
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004137.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794032 | Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv | Dec 21, 2005 | Abandoned |
Array
(
[id] => 4533778
[patent_doc_number] => 07871987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Ester derivatives of ascorbic and 2-keto acid saccharides'
[patent_app_type] => utility
[patent_app_number] => 11/792460
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 10570
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/871/07871987.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792460 | Ester derivatives of ascorbic and 2-keto acid saccharides | Dec 15, 2005 | Issued |
Array
(
[id] => 5656474
[patent_doc_number] => 20060142210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture'
[patent_app_type] => utility
[patent_app_number] => 11/304284
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8543
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304284 | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | Dec 14, 2005 | Issued |
Array
(
[id] => 5254053
[patent_doc_number] => 20070135509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Indolone compounds useful to treat cognitive impairment'
[patent_app_type] => utility
[patent_app_number] => 11/298116
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11945
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20070135509.pdf
[firstpage_image] =>[orig_patent_app_number] => 11298116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/298116 | Indolone compounds useful to treat cognitive impairment | Dec 8, 2005 | Abandoned |
Array
(
[id] => 4887491
[patent_doc_number] => 20080261823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides'
[patent_app_type] => utility
[patent_app_number] => 11/792968
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6327
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792968 | Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides | Dec 8, 2005 | Abandoned |
Array
(
[id] => 348890
[patent_doc_number] => 07495006
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => '2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/301326
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 45367
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495006.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301326
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301326 | 2′ and 3′-substituted cyclobutyl nucleoside analogs for the treatment of viral infections and abnormal cellular proliferation | Dec 7, 2005 | Issued |
Array
(
[id] => 5694742
[patent_doc_number] => 20060154889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Polyfluorinated nucleoside analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/295306
[patent_app_country] => US
[patent_app_date] => 2005-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18149
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295306
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295306 | Polyfluorinated nucleoside analogs and methods of use thereof | Dec 4, 2005 | Abandoned |
Array
(
[id] => 185602
[patent_doc_number] => 07645876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-12
[patent_title] => 'Processes for producing crystalline macrolides'
[patent_app_type] => utility
[patent_app_number] => 11/293747
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5001
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/645/07645876.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293747 | Processes for producing crystalline macrolides | Nov 30, 2005 | Issued |
Array
(
[id] => 4826850
[patent_doc_number] => 20080125394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Oral Compositions for Absorption of Phosphorus Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/792047
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5258
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125394.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792047
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792047 | Oral compositions for absorption of phosphorus compounds | Nov 28, 2005 | Issued |
Array
(
[id] => 356317
[patent_doc_number] => 07488753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/289142
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 18483
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488753.pdf
[firstpage_image] =>[orig_patent_app_number] => 11289142
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/289142 | Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof | Nov 27, 2005 | Issued |
Array
(
[id] => 5705708
[patent_doc_number] => 20060194756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/286129
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34974
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286129
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286129 | Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonists | Nov 21, 2005 | Abandoned |
Array
(
[id] => 5776423
[patent_doc_number] => 20060105063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Synergic combination of compositions containing aloe vera isolates and their therapeutic application'
[patent_app_type] => utility
[patent_app_number] => 11/281314
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9947
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105063.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281314 | Synergic combination of compositions containing aloe vera isolates and their therapeutic application | Nov 16, 2005 | Abandoned |
Array
(
[id] => 5215673
[patent_doc_number] => 20070104754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Method and system for treatment of eating disorders'
[patent_app_type] => utility
[patent_app_number] => 11/270397
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10512
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270397 | Method and system for treatment of eating disorders | Nov 7, 2005 | Issued |
Array
(
[id] => 5748378
[patent_doc_number] => 20060111310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/267523
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 10754
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111310.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267523
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267523 | Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof | Nov 3, 2005 | Abandoned |
Array
(
[id] => 5614421
[patent_doc_number] => 20060116349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Methods and compositions for administration of iron for the treatment of restless leg syndrome'
[patent_app_type] => utility
[patent_app_number] => 11/263510
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8737
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11263510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/263510 | Methods and compositions for administration of iron for the treatment of restless leg syndrome | Oct 30, 2005 | Abandoned |
Array
(
[id] => 5710988
[patent_doc_number] => 20060052333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method of treating arrhythmias'
[patent_app_type] => utility
[patent_app_number] => 11/262025
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11428
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262025
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262025 | Method of treating arrhythmias | Oct 27, 2005 | Issued |
Array
(
[id] => 53704
[patent_doc_number] => 07772439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Amino or thiol linker building block for the synthesis of amino- or thiol-functionalized nucleic acids and methods of making and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/257752
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2133
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772439.pdf
[firstpage_image] =>[orig_patent_app_number] => 11257752
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/257752 | Amino or thiol linker building block for the synthesis of amino- or thiol-functionalized nucleic acids and methods of making and use thereof | Oct 24, 2005 | Issued |
Array
(
[id] => 4860313
[patent_doc_number] => 20080269163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis'
[patent_app_type] => utility
[patent_app_number] => 11/577555
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 32194
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269163.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577555 | Methods and Compositions for Protecting Cells from Ultrasound-Mediated Cytolysis | Oct 18, 2005 | Abandoned |
Array
(
[id] => 5297112
[patent_doc_number] => 20090012038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Methods for microbial biofilm destruction and interference with microbial cellular physiology'
[patent_app_type] => utility
[patent_app_number] => 11/665418
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13463
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012038.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665418
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665418 | Methods for microbial biofilm destruction and interference with microbial cellular physiology | Oct 17, 2005 | Abandoned |
Array
(
[id] => 53270
[patent_doc_number] => 07772220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Methods and compositions for reducing toxicity of a pharmaceutical compound'
[patent_app_type] => utility
[patent_app_number] => 11/251137
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 7613
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772220.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251137
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251137 | Methods and compositions for reducing toxicity of a pharmaceutical compound | Oct 13, 2005 | Issued |